Literature DB >> 23728492

A closer look at osteoarthritis.

Lora R Shelton1.   

Abstract

Osteoarthritis (OA) is the most common form of arthritis affecting 26.9 million Americans. OA is a degenerative disorder of the synovial joint that leads to pain, stiffness, and decreased function of the affected joint. An understanding of both the nonpharmacologic and pharmacologic management of OA is essential for nurse practitioners.

Entities:  

Mesh:

Year:  2013        PMID: 23728492     DOI: 10.1097/01.NPR.0000431178.49311.42

Source DB:  PubMed          Journal:  Nurse Pract        ISSN: 0361-1817


  3 in total

1.  Activity limitation and participation restriction in Osteoarthritis and Rheumatoid arthritis: findings based on the National Health and Nutritional Examination Survey.

Authors:  John Marwa Gikaro; Hao Xiong; Feng Lin
Journal:  BMC Musculoskelet Disord       Date:  2022-07-06       Impact factor: 2.562

Review 2.  Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.

Authors:  Mi Zhang; Wenhui Hu; Chenhui Cai; Yu Wu; Jianmei Li; Shiwu Dong
Journal:  Mater Today Bio       Date:  2022-02-21

3.  Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1.

Authors:  Huiyu Zhang; Yue Lu; BingBing Wu; Fei Xia
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.